Aadi, LLC   Report issue

For profit Phase 1 Phase 2
Founded: Pacific Palisades CA United States (2011)

Organization Overview

First Clinical Trial
2014
NCT02009332
First Marketed Drug
2021
sirolimus (rapamune)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

AADI | Aadi, LLC